MARGINAL ZONE LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (MZL‐IPI): A PROGNOSTIC SCORE FOR THE ENTIRE SPECTRUM OF MARGINAL ZONE LYMPHOMAS. A FIL AND SPORE‐MER STUDY.

Authors :: Luminari, S.
Bommier, C.
Fabbri, N.
Nizzoli, M. E.
Maurer, M. J.
Tarantino, V.
Ferrero, S.
Rattotti, S.
Merli, M.
Ferrari, A.
Murru, R.
Khurana, A.
Mwangi, R.
Deodato, M.
Del Giudice, I.
Cencini, E.
Re, F.
Visco, C.
Feldman, A. L.
Link, B. K.
Source :: Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p102-103, 2p
Publication Year :: 2023
Abstract: In the validation using the MER cohort of 192 MZL patients, 5y PFS was 57% (95% CI 51-64). Applying the MZL-IPI to the MER, 41(21%), 113 (59%), and 38 (20%) patients were classified as LRG, IRG, and HRG, respectively. B Conclusions: b MZL-IPI is a new validated prognostic score for all patients with MZL who are considered for systemic treatment. [Extracted from the article]

Subjects :: MUCOSA-associated lymphoid tissue lymphoma
LYMPHOMAS
LYMPHOPENIA

Full Text Access

Tools